Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

ASCO 2020 – Dr. Lillian L. Siu Receives the International Women Who Conquer Cancer Mentorship Award!

ASCO 2020 – Dr. Lillian L. Siu Receives the International Women Who Conquer Cancer Mentorship Award!

The American Society of Clinical Oncology—ASCO for short—is one of the world's largest oncology communities. At its annual congress held in Chicago, United States, in the first week of June, it presents ASCO Awards in different categories to scientists who have made major contributions to oncology. One of these awards is presented to women mentors (leaders and guides) who play an important role in training the next generation of oncologists. Through The Women Who Conquer Cancer (WWCC) program, ASCO supports young women researchers in developing their careers and remaining in the field. It also recognizes women who have dedicated their time, energy and expertise to the development of oncology professionals, making their names known worldwide. This year, because of the COVID-19 Pandemic, the congress will be broadcast online. The distinguished researcher selected to receive the “International Women Who Conquer Cancer Mentorship Award” is Dr. Lillian L. Siu! Alongside her academic achievements, Dr. Siu has mentored more than 50 young physicians and researchers worldwide, training the successful oncologists/cancer researchers of the future. Let us get to know her more closely.

Dr. Lillian L. Siu is a senior Medical Oncologist at Princess Margaret Cancer Centre and a professor at the University of Toronto Faculty of Medicine. She coordinates the Cancer Centre's “Phase I Program” and “Cancer Genomics Program” and is the clinical lead of its “Tumor Immunotherapy Program.” Dr. Siu is also the principal investigator of the Princess Margaret Phase I Consortium as part of the United States National Cancer Institute's Experimental Therapeutics Clinical Trials Network. In addition to serving on the ASCO Board of Directors, she also serves on its Cancer Education Committee. She is a Fellow of The Royal College of Physicians of Canada (FRCPC) and a Fellow of the American Society of Clinical Oncology (FASCO).

“This award has a very special meaning because of the mentees and colleagues who nominated me. I would like to express my gratitude to my past and present mentees and to the colleagues who supported my nomination. I am greatly honored to receive this award.” – (Quoted from Dr. Siu's interview with the American Society of Clinical Oncology (ASCO-Daily News).)

The Mentor–Mentee (Advisor–Advisee) Relationship is extremely important for the development of future physicians and researchers. Mentors also play a key role in training oncologists and scientists who will shape future cancer research and bring hope to millions of patients with cancer. Dr. Siu has extensive experience both as a mentor and as a mentee. The mentors who have held an important place in her life have profoundly influenced her career. She learned to view the literature critically with the guidance of Dr. Ian Tannock, one of the leading figures in oncology worldwide; Dr. Malcolm Moore taught her about clinical research, and Dr. Gail Eckhardt introduced her to “Developmental Therapeutics.” She expresses this in her own words: “All three of my mentors helped me chart my own career path by offering advice, support and guidance.”

From Mentee to Mentor

Dr. Siu mentors medical students, residents, specialists and young researchers not only in the United States and Canada but around the world. In total, she has guided more than 50 mentees and continues working to reach more young people. Believing that mentorship must be “personalized” and adapted to the individual needs of a mentee to succeed, Dr. Siu says: “I believe the most important element of mentorship is enabling a mentee to recognize and fulfill their own potential.”

Dr. Siu has developed a mentoring style based on frequent face-to-face meetings with her mentees. She notes that these meetings are not limited to work-related matters but cover issues concerning life as a whole. Throughout the process, she supports her mentees' original research ideas, helps them publish scientific studies, and contributes to their development by providing feedback at every stage of their work. Through all this guidance, young researchers gain opportunities to present their own research on national and international platforms.

Looking Ahead

Dr. Siu thanks the many people who have guided her throughout her career and continues to inspire others in the same way. Looking ahead, she emphasizes that cancer research will be “patient-centered”. She also states that drug development in oncology will become “personalized,” meaning that drugs will be developed specifically to match the genetics of each patient and disease. She says these processes will also include innovative techniques such as “artificial intelligence” and “adaptive, specialized clinical trial” designs (adaptive clinical trial designs).

In her interview, she also says that oncologists' support for one another and sharing strengthen cancer research. Researchers in Princess Margaret Cancer Centre's Drug Development Program, who gather for a dinner meeting at ASCO each year, are an excellent example.

“It is wonderful to see the number of people attending this dinner meeting grow and former attendees form stronger connections here. Many of the people here also collaborate on academic research projects through the interactions they established during their training.” – (Quoted from Dr. Siu's interview with the American Society of Clinical Oncology (ASCO-Daily News))

These meetings, whether formal or informal, make a major contribution to researchers' work and career advancement in oncology. Dr. Siu expresses her pride in her young researchers as follows: “I am proud of my mentees who are now international leaders in drug development. Many have also become known as good mentors and have carried this interaction forward to future generations.” Undoubtedly, helping one another move forward will also help cancer research advance.

Finally, she addresses young oncologists at the beginning of their careers: “My life motto consists of 3C: Curious, Courageous, Compassionate (Be curious, courageous and compassionate!). These three words have helped me throughout my career as I created my own opportunities, made good friends and learned from my mistakes.” The presence of accomplished oncologists and researchers such as Dr. Lillian L. Siu, and the support they provide to young scientist-physicians by investing their time and effort, strengthen our faith in brighter, better days ahead.

Sources

Dr. Lillian L. Siu Honored With 2020 International Women Who Conquer Cancer Mentorship Award.
dailynews.ascopubs.org - 6 May 2020

Appointment request

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

ASCO 2020 – Dr. Lillian L. Siu Receives the International Women Who Conquer Cancer Mentorship Award!

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy